A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Clinical trial NCT02642432 · COMPLETED

Trial details

NCT number: NCT02642432
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus Infection Chronic Hepatitis C Compensated Cirrhosis

Start date: 2015-12-07
Primary completion: 2016-10-27
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.